XRCC2 and neoplasm: Ten genes (CHEK2, XRCC2, MCM6, MAP3K4, MMP14, APOA1, WHSC1L1, IDO1, ST3GAL-4 and A1CF) were selected for validation based on the significance threshold, high expression in tumour tissue and plausible biological function.